Cargando…

Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation

BACKGROUND: Brain-derived neurotrophic factor (BDNF) exerts beneficial effects not only on diabetic neuropathies but also on cardiovascular injury. There is argument regarding the levels of serum BDNF in patients with diabetes mellitus (DM). Because BDNF in peripheral blood is rich in platelets, thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furukawa, Kazuo, Fuse, Ichiro, Iwakura, Yuriko, Sotoyama, Hidekazu, Hanyu, Osamu, Nawa, Hiroyuki, Sone, Hirohito, Takei, Nobuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299653/ https://www.ncbi.nlm.nih.gov/pubmed/28178976 http://dx.doi.org/10.1186/s12933-017-0505-y

Ejemplares similares

A possible link between BDNF and mTOR in control of food intake
por: Takei, Nobuyuki, et al.
Publicado: (2014)

Neuropathologic Implication of Peripheral Neuregulin-1 and EGF Signals in Dopaminergic Dysfunction and Behavioral Deficits Relevant to Schizophrenia: Their Target Cells and Time Window
por: Nawa, Hiroyuki, et al.
Publicado: (2014)

Clozapine-dependent inhibition of EGF/neuregulin receptor (ErbB) kinases
por: Kobayashi, Yutaro, et al.
Publicado: (2019)

Inter‐breeder differences in prepulse inhibition deficits of C57BL/6J mice in a maternal immune activation model
por: Kobayashi, Yutaro, et al.
Publicado: (2021)

Pallidal Hyperdopaminergic Innervation Underlying D2 Receptor-Dependent Behavioral Deficits in the Schizophrenia Animal Model Established by EGF
por: Sotoyama, Hidekazu, et al.
Publicado: (2011)

Glutamate-dependent ectodomain shedding of neuregulin-1 type II precursors in rat forebrain neurons
por: Iwakura, Yuriko, et al.
Publicado: (2017)

Role of Src in Vascular Hyperpermeability Induced by Advanced Glycation End Products
por: Zhang, Weijin, et al.
Publicado: (2015)

Schizophrenia Animal Modeling with Epidermal Growth Factor and Its Homologs: Their Connections to the Inflammatory Pathway and the Dopamine System
por: Sotoyama, Hidekazu, et al.
Publicado: (2023)

ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease
por: Iwakura, Yuriko, et al.
Publicado: (2013)

ErbB2 Dephosphorylation and Anti-Proliferative Effects of Neuregulin-1 in ErbB2-Overexpressing Cells; Re-evaluation of Their Low-Affinity Interaction
por: Wang, Ran, et al.
Publicado: (2013)

Reversible brain atrophy and cognitive impairment in an adolescent Japanese patient with primary adrenal Cushing’s syndrome
por: Ohara, Nobumasa, et al.
Publicado: (2014)

ErbB inhibitors ameliorate behavioral impairments of an animal model for schizophrenia: implication of their dopamine-modulatory actions
por: Mizuno, M, et al.
Publicado: (2013)

Neuropathy induced by exogenously administered advanced glycation end‐products in rats
por: Nishizawa, Yusuke, et al.
Publicado: (2010)

mTOR signaling and its roles in normal and abnormal brain development
por: Takei, Nobuyuki, et al.
Publicado: (2014)

Sound frequency dependence of duration mismatch negativity recorded from awake rats
por: Inaba, Hiroyoshi, et al.
Publicado: (2019)

Hypertrophic pachymeningitis associated with myelodysplastic syndrome
por: Kaihatsu, Akane, et al.
Publicado: (2020)

The (Patho)Biology of SRC Kinase in Platelets and Megakaryocytes
por: De Kock, Lore, et al.
Publicado: (2020)

Neonatal exposure to an inflammatory cytokine, epidermal growth factor, results in the deficits of mismatch negativity in rats
por: Jodo, Eiichi, et al.
Publicado: (2019)

Resting-state dopaminergic cell firing in the ventral tegmental area negatively regulates affiliative social interactions in a developmental animal model of schizophrenia
por: Sotoyama, Hidekazu, et al.
Publicado: (2021)

Increased self-triggered vocalizations in an epidermal growth factor-induced rat model for schizophrenia
por: Narihara, Itaru, et al.
Publicado: (2022)

Acetaldehyde-Derived Advanced Glycation End-Products Promote Alcoholic Liver Disease
por: Hayashi, Nobuhiko, et al.
Publicado: (2013)

Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023)

Altered Expression of NF-κB and SP1 after Exposure to Advanced Glycation End-Products and Effects of Neurotrophic Factors in AGEs Exposed Rat Retinas
por: Bikbova, Guzel, et al.
Publicado: (2015)

Hesperetin treatment attenuates glycation of lens proteins and advanced‑glycation end products generation
por: Doki, Yuri, et al.
Publicado: (2023)

Advanced Glycation End Products and Bone Metabolism in Patients with Chronic Kidney Disease
por: Quadros, Kélcia R. S., et al.
Publicado: (2023)

Fingertip advanced glycation end products and psychotic symptoms among adolescents
por: Miyashita, Mitsuhiro, et al.
Publicado: (2021)

Platelet Src family kinases: A tale of reversible phosphorylation
por: Senis, Yotis A., et al.
Publicado: (2021)

Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010)

Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014)

Advanced Glycation End Products in the Pathogenesis of Psoriasis
por: Papagrigoraki, Anastasia, et al.
Publicado: (2017)

Toxicity of advanced glycation end products (Review)
por: Kuzan, Aleksandra
Publicado: (2021)

Advanced Glycation End Products in Health and Disease
por: Reddy, V. Prakash, et al.
Publicado: (2022)

The Role of Advanced Glycation End Products on Dyslipidemia
por: Vekic, Jelena, et al.
Publicado: (2023)

Glycation of fibronectin inhibits VEGF‐induced angiogenesis by uncoupling VEGF receptor‐2‐c‐Src crosstalk
por: Chen, Tangting, et al.
Publicado: (2020)

Evidence for Activation of Toll-Like Receptor and Receptor for Advanced Glycation End Products in Preterm Birth
por: Noguchi, Taketoshi, et al.
Publicado: (2010)

Association of Helicobacter pylori Infection with Glycemic Control in Patients with Diabetes: A Meta-Analysis
por: Horikawa, Chika, et al.
Publicado: (2014)

Influence of Physical Activity Intervention on Circulating Soluble Receptor for Advanced Glycation end Products in Elderly Subjects
por: Kotani, Kazuhiko, et al.
Publicado: (2011)

AMPK activation, eEF2 inactivation, and reduced protein synthesis in the cerebral cortex of hibernating chipmunks
por: Yamada, Shintaro, et al.
Publicado: (2019)

Neuroprotective Effects of Endogenous Secretory Receptor for Advanced Glycation End-products in Brain Ischemia
por: Shimizu, Yu, et al.
Publicado: (2019)

The Receptor for Advanced Glycation End Products (RAGE) and the Lung
por: Buckley, Stephen T., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_pmdu4h0qihlh2jqerpidm6nfto